Small-Vessel Vasculitis Studies
If you are interested in learning more about a study, email our research group at rheumatologyresearch@uphs.upenn.edu.
|
Study Name
|
Currently Enrolling
|
Disease Studied
|
Drug Study
|
| Study to Investigate the Efficacy and Safety of NS-229 in the Treatment of Eosinophilic Granulomatosis with Polyangiitis |
YES |
EGPA |
YES |
| Determinants of Systemic Immune Reactivation in ANCA Associated Vasculitis (DORA) |
YES |
GPA, MPA, EGPA |
NO |
| The Assessment of Prednisone in Remission Trial (TAPIR) |
NO |
GPA |
YES |
| 5506: The EGPA Registry |
YES |
EGPA |
NO |
| Nasal Microbiome in ANCA Associated Vasculitis and Relapsing Polychondritis (NMB) |
YES |
EGPA & RP |
NO |
| Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis (LoDoNaVasc) |
YES |
GPA, MPA, EGPA, GCA, TAK, PAN |
YES |
| One-Time DNA Study for Vasculitis (OTD) |
YES |
GPA, MPA, EGPA, GCA, TAK, PAN |
NO |
| Clinical Transcriptomics in Systemic Vasculitis (CUTIS) |
YES |
GPA, MPA, EGPA, PAN, IgAV, cryoglobulinemic, drug-induced, isolated cutaneous small vessel vasculitis, urticarial |
NO |
| Tissue Repository Collection Protocol |
YES |
GPA, MPA, EGPA, GCA, TAK, PAN, cutaneous vasculitis |
NO |
| A Randomized Multicenter Study for Isolated Skin Vasculitis (ARAMIS) |
YES |
Cutaneous small/medium vessel vasculitis, cPAN, or IgA vasculitis |
YES |
| Depemokimab compared with mepolizumab for relapsing or refractory EGPA on standard of care therapy (OCEAN) |
YES |
EGPA |
YES |
